get semaglutide prescription covington GLP-1s Weight loss isn't one-size-fits-all—and neither
Description
Evidence now warrants a focus on the beta cell itself and how to avoid its dysfunction, which is putatively caused by cytokine-driven inflammation and other stress factors, leading to low insulin-secretory capacity, autoantigen presentation and immune-mediated destruction
A 34-year-old woman with a 23-year history of T1DM presented for review for weight gain (weight 63 kg, BMI 26.9 kg/m2) and increased HbA1c (8.3%) and glycemic variability
Early clinical results suggest the treatment is safe and well tolerated.
Semaglutide injections require precise storage conditions to maintain potency
2020;12(3):859
Semaglutide (aka Ozempic and Wegovy), a GLP-1 agonist, and tirzepatide (aka Mounjaro and Zepbound), a combined GLP-1 and GIP agent, are the latest rage in
